These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 1394336

  • 1. Active specific immunotherapy with Newcastle-disease-virus-modified autologous tumor cells following resection of liver metastases in colorectal cancer. First evaluation of clinical response of a phase II-trial.
    Schlag P, Manasterski M, Gerneth T, Hohenberger P, Dueck M, Herfarth C, Liebrich W, Schirrmacher V.
    Cancer Immunol Immunother; 1992; 35(5):325-30. PubMed ID: 1394336
    [Abstract] [Full Text] [Related]

  • 2. In vitro and clinical characterisation of a Newcastle disease virus-modified autologous tumour cell vaccine for treatment of colorectal cancer patients.
    Liebrich W, Schlag P, Manasterski M, Lehner B, Stöhr M, Möller P, Schirrmacher V.
    Eur J Cancer; 1991; 27(6):703-10. PubMed ID: 1829908
    [Abstract] [Full Text] [Related]

  • 3. Postoperative active specific immunization in curatively resected colorectal cancer patients with a virus-modified autologous tumor cell vaccine.
    Lehner B, Schlag P, Liebrich W, Schirrmacher V.
    Cancer Immunol Immunother; 1990; 32(3):173-8. PubMed ID: 2289211
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal cancer patients following resection of liver metastases: results of a prospective randomized trial.
    Schulze T, Kemmner W, Weitz J, Wernecke KD, Schirrmacher V, Schlag PM.
    Cancer Immunol Immunother; 2009 Jan; 58(1):61-9. PubMed ID: 18488223
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of metastatic melanoma with an autologous tumor-cell vaccine: clinical and immunologic results in 64 patients.
    Berd D, Maguire HC, McCue P, Mastrangelo MJ.
    J Clin Oncol; 1990 Nov; 8(11):1858-67. PubMed ID: 2230873
    [Abstract] [Full Text] [Related]

  • 9. [Adjuvant therapy of liver metastases: active specific immunotherapy].
    Hagmüller E, Beck N, Ockert D, Schirrmacher V.
    Zentralbl Chir; 1995 Nov; 120(10):780-5. PubMed ID: 7502592
    [Abstract] [Full Text] [Related]

  • 10. Specific immunotherapy of colorectal carcinoma with Newcastle-disease virus-modified autologous tumor cells prepared from resected liver metastasis.
    Schirrmacher V, Schlag P, Liebrich W, Patel BT, Stoeck M.
    Ann N Y Acad Sci; 1993 Aug 12; 690():364-6. PubMed ID: 8368757
    [No Abstract] [Full Text] [Related]

  • 11. A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: cancer and leukemia group B study 89903.
    Posner MC, Niedzwiecki D, Venook AP, Hollis DR, Kindler HL, Martin EW, Schilsky RL, Goldberg RM, Mayer RJ.
    Ann Surg Oncol; 2008 Jan 12; 15(1):158-64. PubMed ID: 18008108
    [Abstract] [Full Text] [Related]

  • 12. Adjuvant active specific immunotherapy for human colorectal cancer: 6.5-year median follow-up of a phase III prospectively randomized trial.
    Hoover HC, Brandhorst JS, Peters LC, Surdyke MG, Takeshita Y, Madariaga J, Muenz LR, Hanna MG.
    J Clin Oncol; 1993 Mar 12; 11(3):390-9. PubMed ID: 8445413
    [Abstract] [Full Text] [Related]

  • 13. Antitumor immunization of head and neck squamous cell carcinoma patients with a virus-modified autologous tumor cell vaccine.
    Herold-Mende C, Karcher J, Dyckhoff G, Schirrmacher V.
    Adv Otorhinolaryngol; 2005 Mar 12; 62():173-83. PubMed ID: 15608427
    [Abstract] [Full Text] [Related]

  • 14. Clinical trials of antitumor vaccination with an autologous tumor cell vaccine modified by virus infection: improvement of patient survival based on improved antitumor immune memory.
    Schirrmacher V.
    Cancer Immunol Immunother; 2005 Jun 12; 54(6):587-98. PubMed ID: 15838708
    [Abstract] [Full Text] [Related]

  • 15. Antitumor vaccination in patients with head and neck squamous cell carcinomas with autologous virus-modified tumor cells.
    Karcher J, Dyckhoff G, Beckhove P, Reisser C, Brysch M, Ziouta Y, Helmke BH, Weidauer H, Schirrmacher V, Herold-Mende C.
    Cancer Res; 2004 Nov 01; 64(21):8057-61. PubMed ID: 15520216
    [Abstract] [Full Text] [Related]

  • 16. Active immunotherapy of human melanoma exploiting the immunopotentiating effects of cyclophosphamide.
    Berd D, Mastrangelo MJ.
    Cancer Invest; 1988 Nov 01; 6(3):337-49. PubMed ID: 3167614
    [Abstract] [Full Text] [Related]

  • 17. A 15-year follow-up of AJCC stage III malignant melanoma patients treated postsurgically with Newcastle disease virus (NDV) oncolysate and determination of alterations in the CD8 T cell repertoire.
    Batliwalla FM, Bateman BA, Serrano D, Murray D, Macphail S, Maino VC, Ansel JC, Gregersen PK, Armstrong CA.
    Mol Med; 1998 Dec 01; 4(12):783-94. PubMed ID: 9990864
    [Abstract] [Full Text] [Related]

  • 18. Adjuvant immunotherapy treatment of renal carcinoma patients with autologous tumor cells and bacillus Calmette-Guèrin: five-year results of a prospective randomized study.
    Galligioni E, Quaia M, Merlo A, Carbone A, Spada A, Favaro D, Santarosa M, Sacco C, Talamini R.
    Cancer; 1996 Jun 15; 77(12):2560-6. PubMed ID: 8640706
    [Abstract] [Full Text] [Related]

  • 19. Irradiated cells from autologous tumor cell lines as patient-specific vaccine therapy in 125 patients with metastatic cancer: induction of delayed-type hypersensitivity to autologous tumor is associated with improved survival.
    Dillman RO, Beutel LD, Barth NM, de Leon C, O'Connor AA, DePriest C, Nayak SK.
    Cancer Biother Radiopharm; 2002 Feb 15; 17(1):51-66. PubMed ID: 11915174
    [Abstract] [Full Text] [Related]

  • 20. LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases: a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trial.
    Schimanski CC, Möhler M, Schön M, van Cutsem E, Greil R, Bechstein WO, Hegewisch-Becker S, von Wichert G, Vöhringer M, Heike M, Heinemann V, Peeters M, Kanzler S, Kasper S, Overkamp F, Schröder J, Seehofer D, Kullmann F, Linz B, Schmidtmann I, Smith-Machnow V, Gockel I, Lang H, Galle PR.
    BMC Cancer; 2012 Apr 11; 12():144. PubMed ID: 22494623
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.